Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Problems associated with rabies preexposure prophylaxis

W R Garner, D O Jones, E Pratt

    JAMA
    |March 15, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparing the effectiveness of nasal dilator strips: does race play a role?

    The Journal of laryngology and otology·2014
    Same author

    Nasal peak inspiratory flow (NPIF) as a diagnostic tool for differentiating decongestable from structural nasal obstruction.

    Rhinology·2014
    Same author

    Modified Lund Mackay Postoperative Endoscopy Score for defining inflammatory burden in chronic rhinosinusitis.

    Rhinology·2014
    Same author

    The role of configuration and target discriminability in a visual search task.

    Memory & cognition·2013
    Same author

    Patient self-assessment in discriminating the more obstructed side in nasal breathing.

    The Journal of laryngology and otology·2013
    Same author

    Osteitic bone: a surrogate marker of eosinophilia in chronic rhinosinusitis.

    Rhinology·2012
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    Same journal

    FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

    JAMA·2026
    Same journal

    HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

    JAMA·2026
    Same journal

    US Dietary Supplement Use Increasing, Especially in Older Adults.

    JAMA·2026
    Same journal

    Heat Stress From Climate Change Surges Globally.

    JAMA·2026
    Same journal

    Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

    JAMA·2026
    See all related articles

    New rabies vaccines derived from cell cultures show high efficacy in individuals who do not respond to current vaccines or have allergies. These experimental vaccines achieved seroconversion in all volunteers with only minor side effects.

    Area of Science:

    • Immunology
    • Vaccinology
    • Virology

    Background:

    • Current rabies vaccines for preexposure prophylaxis have limitations, with 20% of individuals failing to achieve seroconversion and 5% experiencing allergic reactions.
    • Duck embryo rabies vaccine is a common preexposure prophylaxis, but its efficacy and tolerability can be issues for certain populations.

    Purpose of the Study:

    • To evaluate the efficacy and safety of two new experimental rabies vaccines of cell culture origin.
    • To assess seroconversion rates in individuals unresponsive or allergic to existing rabies vaccines.

    Main Methods:

    • A double-blind experiment was conducted involving 31 volunteers.
    • Volunteers received either a human diploid cell culture (WI-38) or a hamster kidney-cell culture rabies vaccine.

    Related Experiment Videos

  • Participants included individuals who did not seroconvert or were allergic to the duck embryo rabies vaccine.

    • Main Results:

    • All volunteers achieved seroconversion within 14 days after a single injection of the experimental vaccines.
    • Both the human diploid cell culture (WI-38) and hamster kidney-cell culture vaccines demonstrated high efficacy.
    • Clinical side effects reported were minor, indicating good tolerability.

    Conclusions:

    • Experimental cell culture-derived rabies vaccines are effective and well-tolerated alternatives for preexposure prophylaxis.
    • These novel vaccines offer a promising solution for individuals with inadequate immune responses or allergies to conventional rabies vaccines.